CLBCX
Price
$35.27
Change
-$0.35 (-0.98%)
Updated
Feb 21 closing price
Net Assets
242.17B
ICMVX
Price
$12.97
Change
-$0.19 (-1.44%)
Updated
Feb 21 closing price
Net Assets
87.18M
Ad is loading...

CLBCX vs ICMVX

Header iconCLBCX vs ICMVX Comparison
Open Charts CLBCX vs ICMVXBanner chart's image
American Funds American Balanced 529C
Price$35.27
Change-$0.35 (-0.98%)
VolumeN/A
Net Assets242.17B
Intrepid Capital Institutional
Price$12.97
Change-$0.19 (-1.44%)
VolumeN/A
Net Assets87.18M
CLBCX vs ICMVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBCX vs. ICMVX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Hold and ICMVX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 242B vs. ICMVX (87.2M). ICMVX pays higher dividends than CLBCX: ICMVX (4.00) vs CLBCX (1.52). CLBCX was incepted earlier than ICMVX: CLBCX (23 years) vs ICMVX (15 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. ICMVX (57.00). CLBCX has a lower initial minimum investment than ICMVX: CLBCX (250) vs ICMVX (250000). ICMVX annual gain was more profitable for investors over the last year : 15.61 vs. CLBCX (8.39). ICMVX return over 5 years is better than : 46.93 vs. CLBCX (26.92).
CLBCXICMVXCLBCX / ICMVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years15 years-
Gain YTD2.7681.805153%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets242B87.2M277,523%
Annual Yield % from dividends1.524.0038%
Returns for 1 year8.3915.6154%
Returns for 3 years16.4424.3967%
Returns for 5 years26.9246.9357%
Returns for 10 years53.3743.16124%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFSI101.250.33
+0.33%
PennyMac Financial Services
ANTX1.13N/A
N/A
AN2 Therapeutics
DSGN4.91-0.10
-2.00%
Design Therapeutics
HAL26.26-0.73
-2.70%
Halliburton Company
INDI3.41-0.50
-12.79%
indie Semiconductor